(Q37306164)

19 August 2017

1 reference

title

Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal (English)

1 reference

human papillomavirus infection

19 August 2017

0 references

0 references

0 references

1 reference

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

Neerja Bhatla

2

0 references

Rengaswamy Sankaranarayanan

1

object named as

Rengaswamy Sankaranarayanan

1 reference

19 August 2017

Patti E Gravitt

3

1 reference

19 August 2017

Partha Basu

4

1 reference

19 August 2017

Pulikattil O Esmy

5

1 reference

19 August 2017

K S Ashrafunnessa

6

1 reference

19 August 2017

Yasantha Ariyaratne

7

1 reference

19 August 2017

Aarati Shah

8

1 reference

19 August 2017

Bhagwan M Nene

9

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 August 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

26 Suppl 12

1 reference

19 August 2017

page(s)

M43-52

1 reference

Papillomavirus infection in rural women in southern India

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

A comparative profile of the prevalence and age distribution of human papillomavirus type 16/18 infections among three states of India with focus on northeast India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Men's extramarital sex, marital relationships and sexual risk in urban poor communities in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Human Papillomavirus Type Distribution in Cervical Cancer in Delhi, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Human papillomavirus genotypes associated with cervical neoplasia in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

The role of low-level magnification in visual inspection with acetic acid for the early detection of cervical neoplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Accuracy of conventional cytology: results from a multicentre screening study in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

A critical assessment of screening methods for cervical neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Screening for cervical cancer in India: How much will it cost? A trial based analysis of the cost per case detected

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Determinants of participation of women in a cervical cancer visual screening trial in rural south India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Determinants of womens participation in cervical cancer screening trial, Maharashtra, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

Cost-effectiveness of cervical-cancer screening in five developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

A strategic assessment of cervical cancer prevention and treatment services in 3 districts of Uttar Pradesh, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.005

10.1016/J.VACCINE.2008.05.005

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference